Figures & data
Table 1. Results for some of the more recent epidemiological studies of antiepileptic drugs associated with teratogenesis.
Table 2. Confidential enquiry into maternal death, 1985–2008.
Activity Evaluation: Where 1 is strongly disagree and 5 is strongly agree
Samren EB, Van Duijn CM, Koch S et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia38, 981–990 (1997). Olafsson E, Hallgrimsson JT, Hauser WA, Ludvigsson P, Gudmundsson G. Pregnancies of women with epilepsy: a population based study in Iceland. Epilepsia39(8), 887–892 (1998). Canger R, Battino D, Canevini MP et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia40, 1231–1236 (1999). Canger R, Battino D, Canevini MP et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res.33, 145–158 (1999). Samrén EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D. Antiepileptic drug regimes and major congenital abnormalities. Ann. Neurol.46, 739–746 (1999). Holmes LB, Harvey EA, Coull B, Huntington KB, Khosbin S, Hayes AM. The teratogenicity of anticonvulsant drugs. N. Engl. J. Med.344(15), 1132–1138 (2001). Tomson T, Battino D, Bonizzoni E et al. Collaborative EURAP Study Group 2004. EURAP: an international registry of antiepileptic drugs and pregnancy. Epilepsia45(11), 1463–1464 (2004). Holmes LB, Wyszynski DF. North American antiepileptic drug registry. Epilepsia45(11), 1465 (2004). Vajda FJ, O’Brien TJ, Hitchcock A et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J. Clin. Neurosci.11, 8548 (2004). Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology64, 961–965 (2005). Morrow J, Russell A, Guthrie E et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatry77, 193–198 (2006). Diav-Citrin O, Shechtman S, Bar-Oz B, Cantrell D, Amon J, Omoy A. Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in teratogenic effect. CNS Drugs22(4), 325–334 (2008). Cunnington MC, Weil JG, Messenheimer JA et al. Final results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology76, 1817–1823 (2011).